ISPOR Announces 2019-2020 Board of Directors

Published Jun 10, 2019

Nancy J. Devlin, PhD Moves Into the Role of President

Lawrenceville, NJ, USA—June 10, 2019—ISPOR, the professional society for health economics and outcomes research (HEOR), announced the results of its recent elections and its 2019-2020 Board of Directors. The Society’s membership selects its new president-elect and the 2019-2020 board will assume office on July 1, 2019.

Nancy J. Devlin, PhD—President
Dr Devlin will assume the role of 2019-2020 president after serving as ISPOR’s president-elect over the past year. She is director, Centre for Health Policy at the University of Melbourne in Melbourne, Victoria, Australia.

Jens Grueger, PhD—President-Elect
Dr Grueger was elected president-elect and will move into the role of president during the 2020-2021 term. Most recently he was head of Global Access at F. Hoffmann-La Roche in Basel, Switzerland.

Federico Augustovski, MD, MSc, PhD—Immediate Past President
Dr Augustovski moves into the role of past president and is director of health economic evaluations and technology assessment at the Institute for Clinical Effectiveness and Health Policy in Buenos Aires, Argentina.

Returning board members include:

Meindert Boysen, PharmD—Director
Dr Boysen is director, technology appraisal and highly-specialized technologies programs at the National Institute for Health and Care Excellence, London, England, UK.

Jalpa A. Doshi, PhD—Director
Dr Doshi is professor of medicine at the University of Pennsylvania, Philadelphia, PA, USA.

Stephanie R. Earnshaw, PhD—Director
Dr Earnshaw is senior vice president, health economics at RTI Health Solutions, Research Triangle Park, NC, USA.

Jan Elias Hansen, PhD—Director
Dr Hansen is vice president, Evidence for Access Unit, US Medical Affairs at Genentech, South San Francisco, CA, USA.

Neil Hawkins, MSc, MBA, PhD—Director
Dr Hawkins is professor of health technology assessment at the University of Glasgow, Glasgow, Scotland, UK.

Rok Hren, PhD, MSc—Director
Dr Hren is head of laboratory diagnostics, point.of.care and molecular diagnostics in the Adriatic region, Siemens Healthineers, Ljubljana, Slovenia.

Zeba M. Khan, RPh, PhD—Treasurer
Dr Khan is vice president at Celgene Corporation, Summit, NJ, USA.

Raoh-Fang (Jasmine) Pwu, PhD—Director
Dr Pwu is director, National Hepatitis C Program Office, Ministry of Health and Welfare, Taipei, Taiwan.

###

ABOUT ISPOR
ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Web: www.ispor.org | LinkedIn: www.linkedin.com/company/ispororg | Twitter: www.twitter.com/ispororg (@ISPORorg) | YouTube: www.youtube.com/ispororg | Facebook: www.facebook.com/ispororg | Instagram: www.instagram.com/ispororg

Related Stories

Mitch Higashi, PhD Joins ISPOR as Associate Chief Science Officer

Dec 11, 2023

ISPOR—The Professional Society for Health Economics and Outcomes Research announced that Mitch Higashi, PhD has joined the Society’s leadership team as Associate Chief Science Officer.

ISPOR Announces New Chief Science Officer

Aug 28, 2023

ISPOR announced that Laura Pizzi, PharmD, MPH will be assuming the role of Chief Science Officer at the Society. ISPOR’s previous Chief Science Officer, Richard J. Willke, PhD, will be retiring.

ISPOR Announces 2023-2024 Board of Directors

May 30, 2023

ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the results of its recent elections. The Society’s membership selected its new president-elect and 3 new board members.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×